Acrivon Therapeutics Inc (ACRV)
8.63
+0.27
(+3.23%)
USD |
NASDAQ |
May 15, 15:37
Acrivon Therapeutics 1 Year Total Returns (Daily): -37.84% for May 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 14, 2024 | -37.84% |
| May 13, 2024 | -36.95% |
| May 10, 2024 | -32.54% |
| May 09, 2024 | -40.01% |
| May 08, 2024 | -35.25% |
| May 07, 2024 | -33.44% |
| May 06, 2024 | -29.53% |
| May 03, 2024 | -23.89% |
| May 02, 2024 | -32.59% |
| May 01, 2024 | -33.74% |
| April 30, 2024 | -26.16% |
| April 29, 2024 | -18.77% |
| April 26, 2024 | -32.43% |
| April 25, 2024 | -31.14% |
| April 24, 2024 | -21.62% |
| April 23, 2024 | -16.35% |
| April 22, 2024 | -18.99% |
| April 19, 2024 | -9.19% |
| April 18, 2024 | 16.21% |
| April 17, 2024 | 16.97% |
| April 16, 2024 | 13.01% |
| April 15, 2024 | 14.68% |
| April 12, 2024 | 6.62% |
| April 11, 2024 | -6.45% |
| April 10, 2024 | 9.37% |
| Date | Value |
|---|---|
| April 09, 2024 | 9.44% |
| April 08, 2024 | -32.76% |
| April 05, 2024 | -37.33% |
| April 04, 2024 | -42.67% |
| April 03, 2024 | -43.80% |
| April 02, 2024 | -47.28% |
| April 01, 2024 | -42.87% |
| March 28, 2024 | -46.64% |
| March 27, 2024 | -52.64% |
| March 26, 2024 | -51.38% |
| March 25, 2024 | -52.00% |
| March 22, 2024 | -48.97% |
| March 21, 2024 | -47.51% |
| March 20, 2024 | -45.82% |
| March 19, 2024 | -72.65% |
| March 18, 2024 | -71.75% |
| March 15, 2024 | -69.51% |
| March 14, 2024 | -76.01% |
| March 13, 2024 | -74.94% |
| March 12, 2024 | -75.10% |
| March 11, 2024 | -75.30% |
| March 08, 2024 | -77.43% |
| March 07, 2024 | -76.63% |
| March 06, 2024 | -76.99% |
| March 05, 2024 | -76.48% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-85.34%
Minimum
Feb 14 2024
16.97%
Maximum
Apr 17 2024
-55.90%
Average
-60.72%
Median
1 Year Total Returns (Daily) Benchmarks
| MyMD Pharmaceuticals Inc | -95.69% |
| Vincerx Pharma Inc | -53.09% |
| GlycoMimetics Inc | -85.62% |
| Immunic Inc | -26.44% |
| Skye Bioscience Inc | 224.0% |